Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypotonic vs Eutonic Treprostinil for Infusion Site Pain
NCT01615627Phase 4Withdrawn
- Sponsor
- Jewish General Hospital
- Start
- Jul 2012
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by Jewish General Hospital. Planned start Jul 2012; status: withdrawn.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01615627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01615627.